BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10517113)

  • 1. [Recurrent thromboembolisms despite oral anticoagulation in a 76-year-old patient--Trousseau syndrome].
    Züger M; Demarmels Biasiutti F
    Ther Umsch; 1999 Sep; 56(9):481-3. PubMed ID: 10517113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous low-molecular-weight heparin for treatment of Trousseau's syndrome.
    Züger M; Demarmels Biasiutti F; Wuillemin WA; Furlan M; Lämmle B
    Ann Hematol; 1997 Oct; 75(4):165-7. PubMed ID: 9402851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous heparin infusion for treatment of Trousseau's syndrome.
    Alderman CP; McClure AF; Jersmann HP; Scott SD
    Ann Pharmacother; 1995; 29(7-8):710-3. PubMed ID: 8520087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung adenocarcinoma complicated by Trousseau's syndrome successfully treated by a combination of anticoagulant therapy and chemotherapy.
    Yoshii Y; Numata T; Ishitobi W; Takahashi N; Wakui H; Kojima J; Shimizu K; Hara H; Ishikawa T; Kawaishi M; Saito K; Araya J; Kaneko Y; Nakayama K; Kuwano K
    Intern Med; 2014; 53(16):1835-9. PubMed ID: 25130121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparin in the management of Trousseau's syndrome.
    Walsh-McMonagle D; Green D
    Cancer; 1997 Aug; 80(4):649-55. PubMed ID: 9264346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Off-label use in long-term anticoagulation after liver transplantation due to phenprocoumon-induced hepatic failure].
    Bertsche T; Fritz R; Sauer P; Encke J; Haefeli WE; Walter-Sack I
    Med Klin (Munich); 2005 Dec; 100(12):820-4. PubMed ID: 16453097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trousseau's syndrome treated with long-term subcutaneous lepirudin (case report and review of the literature).
    Andreescu AC; Cushman M; Hammond JM; Wood ME
    J Thromb Thrombolysis; 2001 Feb; 11(1):33-7. PubMed ID: 11248788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulation in patients with heart valve replacement in pregnancy].
    Harenberg J
    Z Kardiol; 1998; 87 Suppl 4():63-7. PubMed ID: 9857469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Schmidt-Lucke C; Paar WD; Stellbrink C; Nixdorff U; Hofmann T; Meurer J; Grewe R; Daniel WG; Hanrath P; Mügge A; Klein HU; Schmidt-Lucke JA
    Thromb Res; 2007; 119(1):27-34. PubMed ID: 16443257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves.
    Maegdefessel L; Linde T; Krapiec F; Hamilton K; Steinseifer U; van Ryn J; Raaz U; Buerke M; Werdan K; Schlitt A
    Thromb Res; 2010 Sep; 126(3):e196-200. PubMed ID: 20659761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heparins and curative treatment of venous thromboembolic disease: meta-analysis].
    Mismetti P; Laporte-Simitsidis S; Leizorovicz A; Decousus H
    Therapie; 1997; 52(1):47-52. PubMed ID: 9183922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Nov; 157(20):2317-21. PubMed ID: 9361572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry).
    Spyropoulos AC; Turpie AG; Dunn AS; Kaatz S; Douketis J; Jacobson A; Petersen H;
    Am J Cardiol; 2008 Oct; 102(7):883-9. PubMed ID: 18805116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P; Carnovali M; Marchiori A;
    Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview.
    Bernardi E; Piccioli A; Oliboni G; Zuin R; Girolami A; Prandoni P
    Thromb Haemost; 2000 Jul; 84(1):22-6. PubMed ID: 10928464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.